Cerebral Arterial Smooth Muscle Contraction by Thromboxane A2

No abstract is available for this paper.

• Publication year

  1977

• Venue

  Stroke

• Publication date

  1977-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.STR.8.4.480PMID 898244
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2.

  1976cited by this paper
• SYNTHESIS AND RELEASE OF PROSTAGLANDINS BY RAT BRAIN SYNAPTOSOMAL FRACTIONS 1

  1976cited by this paper
• The Reliability of Clinical Predictors of Extracranial Artery Disease

  1976cited by this paper
• Cerebral arterial spasm. Part 5: in vitro contractile activity of vasoactive agents including human CSF on human basilar and anterior cerebral arteries.

  1976cited by this paper
• The endogenous biosynthesis of prostaglandins by brain tissue in vitro.

  1976cited by this paper
• Endogenous formation of the prostaglandin endoperoxide metabolite, thromboxane B2, by brain tissue.

  1976cited by this paper
• Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

  1975cited by this paper
• Transient ischemic attacks due to atherosclerosis. A prospective study of 160 patients.

  1975cited by this paper
• Experimental Study on the Genesis of Cerebral Vasospasm

  1975cited by this paper
• Prostaglandin endoperoxides. VII. Novel transformations of arachidonic acid in guinea pig lung.

  1974cited by this paper
• Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins.

  1974cited by this paper
• Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation.

  1974cited by this paper
• An endoperoxide aggregator (Lass), formed in platelets in response to thrombotic stimuli: purification, identification and unique biological significance.

  1974cited by this paper
• Manometric and Biochemical Techniques

  1973cited by this paper
• Clinical Indicators of Extracranial Carotid Artery Disease in Patients With Transient Symptoms

  1973cited by this paper
• EEG and Arteriographical Findings in Carotid Artery Transient Ischemic Attacks (TIAs)

  1973cited by this paper
• Formation and release of prostaglandins by platelets in response to thrombin.

  1970cited by this paper
• Importance of emboli from carotid bifurcation in pathogenesis of cerebral ischemic attacks.

  1970cited by this paper
• Ulcerated atheroma of the carotid artery: arteriographic appearance.

  1969cited by this paper
• Release of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory Drugs

  1969cited by this paper
• Cerebral arterial spasm. 3. Partial purification and characterization of a spasmogenic substance in feline platelets.

  1968cited by this paper
• Ulcerated atheroma of the carotid artery. A cause of transient cerebral ischemia.

  1968cited by this paper
• Embolization and transient blindness from carotid atheroma. Surgical considerations.

  1966cited by this paper
• MURAL THROMBOSIS OF THE INTERNAL CAROTID ARTERY AND SUBSEQUENT EMBOLISM.

  1964cited by this paper
• Direct Tension Recording From Smooth Muscle of Resistance Vessels From Various Organs

  1961cited by this paper
• Cerebrovascular effects of topically applied serotonin in the cat

  1961cited by this paper

• Use of thrombocyte count dynamics after aneurysmal subarachnoid hemorrhage to predict cerebral vasospasm and delayed cerebral ischemia: a retrospective monocentric cohort study

  2025cites this paper
• Role of Neurons and Glia Cells in Wound Healing as a Novel Perspective Considering Platelet as a Conventional Player

  2021cites this paper
• The effects of ginsenosides on platelet aggregation and vascular intima in the treatment of cardiovascular diseases: from molecular mechanisms to clinical applications.

  2020cites this paper
• Post-treatment Antiplatelet Therapy Reduces Risk for Delayed Cerebral Ischemia due to Aneurysmal Subarachnoid Hemorrhage.

  2018cites this paper
• Therapeutically Targeting Platelet-Derived Growth Factor-Mediated Signaling Underlying the Pathogenesis of Subarachnoid Hemorrhage-Related Vasospasm.

  2018cites this paper
• Cerebrovascular effects of vasoactive drugs: in vitro, in vivo and clinical investigations

  2015cites this paper
• Influence of Antiplatelet Drugs on the Outcome of Subarachnoid Hemorrhage Differs with Age.

  2015cites this paper
• Blood–brain barrier and brain fatty acid uptake: Role of arachidonic acid and PGE2

  2015cites this paper
• Platelet-derived growth factor-β expression in rabbit models of cerebral vasospasm following subarachnoid hemorrhage.

  2014cites this paper
• Lipopolysaccharide-induced blood brain barrier permeability is enhanced by alpha-synuclein expression.

  2013cites this paper
• Role of hemodynamic forces in the regulation of cerebral blood flow

  2013cites this paper
• Effect of Thromboxane Synthetase Inhibitor and Nizofenone on Prevention of Vasospasm after Subarachnoid Hemorrhage

  2012cites this paper
• Blockade of the TP receptor attenuates the exercise pressor reflex in decerebrated rats with chronic femoral artery occlusion.

  2011cites this paper
• Up-regulation of thromboxane A2 impairs cerebrovascular eNOS function in aging atherosclerotic mice

  2011cites this paper
• Isolated Human and Rat Cerebral Arteries Constrict to Increases in Flow: Role of 20-HETE and TP Receptors

  2011cites this paper
• PROGRESS IN CEREBROVASCULAR DISEASE Biology and Therapeutic

  2008cites this paper
• Basic and translational research on proteinase-activated receptors: the role of thrombin receptor in cerebral vasospasm in subarachnoid hemorrhage.

  2008cites this paper
• Blood-arterial wall barrier disruption to various sized tracers following subarachnoid haemorrhage

  2005cites this paper
• An Official Journal of the American Heart Association Mechanism of Action of Carbocyclic Thromboxane A2 and Its Interaction with Prostaglandin I2 and Verapamil in Isolated Arteries

  2005cites this paper
• VASCULAR OCCLUSION AH 23848 * : a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A 2

  2005cites this paper
• Barbiturates in Focal Ischemia of Primate Cortex : Effects on Blood Flow Distribution , Evoked Potential and Extracellular Potassium

  2005cites this paper
• The pathophysiology of cerebral vasospasm, and pharmacological approaches to its management

  2005cites this paper
• Strokes, Transient Ischemic Attacks and Asymptomatic Bruits

  2005cites this paper
• Effect of intracisternal thromboxane A2 analogue on cerebral artery permeability

  2005cites this paper
• Prostaglandin I 2 and Indomethacin Prevent Impairment of Post-Ischemic Brain Reperfusion in the Dog 629

  2005cites this paper
• Role of Prostaglandin I 2 and Thromboxane A 2 in Recurring Reduction of Carotid and Cerebral Blood Flow in Dogs

  2005cites this paper
• Anaerobic change of bloody CSF in subarachnoid haemorrhage. Its relation to cerebral vasospasm

  2005cites this paper
• Effect of the Thromboxane A 2 Mimetic U 46619 on Pial Arterioles of Rabbits and Rats

  2005cites this paper
• Preventive therapy against delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: Trials of thromboxane A2 synthetase inhibitor and hyperdynamic therapy

  2005cites this paper
• Prevention of cerebral vasospasm with OKY-046 an imidazole derivative and a thromboxane synthetase inhibitor. A preliminary co-operative clinical study

  2005cites this paper
• Ultrastructural studies of cerebral vascular spasm after cardiac arrest-related global cerebral ischemia in rats

  2004cites this paper
• Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage.

  2004cites this paper
• Thromboxane A(2) synthase inhibitor enhanced antithrombotic efficacy of GPIIb-IIIa receptor antagonist without increasing bleeding.

  2001cites this paper
• ACTIONS OF ALCOHOL AND ISCHAEMIC BRAIN INFARCTION

  2000cites this paper
• Effects of thromboxane synthetase inhibitor (RS-5186) on experimentally-induced cerebral vasospasm.

  1999cites this paper
• Posttraumatic cerebral ischemia after fluid percussion brain injury: an autoradiographic and histopathological study in rats.

  1998cites this paper
• Direct evidence that thromboxane mimetic U44069 preferentially constricts the afferent arteriole.

  1997cites this paper
• Vasodilator Effects on Canine Basilar Artery Induced by Intracisternal Interleukin-1β

  1997cites this paper
• Correlation between blood parameters and symptomatic vasospasm in subarachnoid hemorrhage patients.

  1997cites this paper
• Thromboxane A2 synthetase inhibitor failed to ameliorate the arterial narrowing during the chronic phase of cerebral vasospasm.

  1997cites this paper
• Thromboxane synthetase inhibitor ameliorates delayed neuronal death in the CA1 subfield of the hippocampus after transient global ischemia in gerbils.

  1996cites this paper
• Inhibition of thromboxane A2 activity during warm ischemia of the liver.

  1996cites this paper
• Widespread Hemodynamic Depression and Focal Platelet Accumulation after Fluid Percussion Brain Injury: A Double-Label Autoradiographic Study in Rats

  1996cites this paper
• Mechanism of Acetylcholine‐Induced Constriction Enhanced by Endothelial Removal in Isolated, Perfused Canine Basilar Arteries

  1995cites this paper
• Mechanisms of cerebral vasospasm in subarachnoid haemorrhage.

  1995cites this paper
• Vasoconstrictor mechanism of neuropeptides augmented after endothelial removal in isolated, perfused canine basilar arteries.

  1995cites this paper
• Drugs Affecting the Cerebrovascular Smooth Muscle

  1994cites this paper
• Thromboxane Antagonism in Experimental Canine Carotid Artery Thrombosis

  1993cites this paper
• Cerebral vasoconstrictor mediators.

  1993cites this paper
• PLATELET ACTIVITY IN PATIENTS TREATED WITH TICLOPIDINE OR SODIUM OZAGREL

  1993cites this paper
• Sequential changes in the platelet count in patients with symptomatic vasospasm after subarachnoid hemorrhage.

  1993cites this paper
• Preventive effect of the thromboxane A2 receptor antagonist S‐1452 (d‐s‐145 Ca) on arachidonate‐induced sudden death and cerebral infarction in rabbits

  1993cites this paper
• Brain protection against ischemic injury by nizofenone.

  1993cites this paper
• Cerebral Vasospasm following Haemorrhagic Stroke

  1993cites this paper
• Pathology of hypertensive arteriopathy.

  1992cites this paper
• S-1452—A Novel TXA2 Receptor Antagonist

  1992cites this paper
• Appearance of collagen fibers in the cerebral vascular wall following subarachnoid hemorrhage.

  1992cites this paper
• Effect of a prostacyclin derivative (OP-41483) and a hyperosmotic agent (glycerol) on brain edema and metabolism in cerebral ischemia.

  1992cites this paper
• 脳血管攣縮に対するトロンボキサン合成酵素阻害剤と Nizofenone の有効性について

  1991cites this paper
• Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage.

  1991cites this paper
• Balloon Transluminal Angioplasty of the Carotid Artery in the Head and Neck

  1991cites this paper
• Effects of subarachnoid hemorrhage and a thromboxane A2 synthetase inhibitor on intracranial prostaglandins.

  1991cites this paper
• Effect of thromboxane A2/endoperoxide antagonist SQ29548 on the contractile response to acetylcholine in newborn piglet cerebral arteries.

  1990cites this paper
• Prevention of Cerebrovascular Spasms With Nimodipine

  1990cites this paper
• Regional differences in the prostanoid receptors mediating prostaglandin F2 alpha-induced contractions of cat isolated arteries.

  1990cites this paper
• Interference of levamisole with cerbral edema

  1990cites this paper
• Platelets as a Source of Vasoactive Mediators

  1990cites this paper
• Regional differences in the prostanoid receptors mediating prostaglandin F2α-induced contractions of cat isolated arteries

  1990cites this paper
• Effect of diltiazem and thromboxane A2 synthetase inhibitor (OKY-046) on vessels following experimental subarachnoid hemorrhage.

  1990cites this paper
• Interference of levamisole with cerebral edema.

  1990cites this paper
• Effects of Prostaglandin I2 and a Selective Thromboxane Synthetase Inhibitor on the Arteriolar Constriction Caused by Norepinephrine

  1990cites this paper
• Role of platelets as a factor aggravating cerebral ischemia.

  1990cites this paper
• Cerebral Vasocontraction Induced by Thrombin-Stimulated Washed Human Platelets - A New In Vitro Model to Study Cerebral Vasospasm

  1990cites this paper
• [The effect of vitamin A on leukotriene production in the ischemic rat brain].

  1989cites this paper
• Atherosclerosis potentiates constrictor responses of cerebral and ocular blood vessels to thromboxane in monkeys.

  1989cites this paper
• Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase.

  1989cites this paper
• [Effect of dazoxiben on cerebrovascular resistance in rabbits].

  1989cites this paper
• Transluminal angioplasty for treatment of intracranial arterial vasospasm.

  1989cites this paper
• Effects of subarachnoid hemorrhage on platelet-derived vasoconstriction of rabbit basilar artery.

  1989cites this paper
• The formation of prostaglandins in the postmortem cerebral cortex of Alzheimer-type dementia patients

  1989cites this paper
• Prevention of chronic cerebral vasospasm in dogs with ibuprofen and high-dose methylprednisolone.

  1989cites this paper
• Regional disparity in the vascular response to subarachnoid hemorrhage--relationship between alteration of the concentration of eicosanoids and electron microscopic findings.

  1989cites this paper
• Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: a randomized double-blind study.

  1989cites this paper
• Transluminal angioplasty of intracerebral vessels for cerebral arterial spasm: reversal of neurological deficits after delayed treatment.

  1989cites this paper
• Actions of a Novel Thromboxane A2‐Receptor Antagonist, S‐145, on Isolated Monkey and Cat Arteries

  1989cites this paper
• Effects of vasospasm on levels of prostacyclin and thromboxane A2 in cerebral arteries of the monkey.

  1988cites this paper
• Racemates: towards a new year resolution?

  1988cites this paper
• Traumatic spinal cord injury in rats causes increases in tissue thromboxane but not peptidoleukotrienes

  1988cites this paper
• Experimental Traumatic Brain Injury Elevates Brain Prostaglandin E2 and Thromboxane B2 Levels in Rats

  1988cites this paper
• The role of the endothelial dependent relaxing factor in the regulation of cerebral circulation.

  1988cites this paper
• Endogenous prostanoids and arterial contractility.

  1988cites this paper
• The Effects of Traumatic Brain Injury on Regional Cerebral Blood Flow in Rats

  1988cites this paper
• The role of the endothelial dependent relaxing factor in the regulation of cerebral circulation

  1988cites this paper
• Endothelium-dependent and independent responses to prostaglandin H2 and arachidonic acid in isolated dog cerebral arteries.

  1988cites this paper
• Role of Prostaglandins in Blood-Induced Vasoconstriction of Canine Cerebral Arteries

  1988cites this paper
• Serotonin and vascular responses.

  1988cites this paper
• Traumatic Brain Injury in the Rat: Effects on Lipid Metabolism, Tissue Magnesium, and Water Content

  1988cites this paper
• Mechanism Underlying Relaxations Caused by Prostaglandins and Thromboxane A2 Analog in Isolated Dog Arteries

  1988cites this paper
• Effect of naloxone and ibuprofen on organ blood flow during endotoxic shock in pig.

  1988cites this paper
• Topographic Peculiarity in Spastic Changes of the Cerebral Artery After Subarachnoid Hemorrhage

  1988cites this paper